![]() |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Lista de Categorias
AlcoolismoAlzheimer E ParkinsonAnalgésicosAnti-InflamatóriosAnti-helmÃnticosAnti-viraisAntialérgicosAntibióticosAnticoncepcionaisAnticonvulsivantesAntidepressivosAntifúngicosArtriteAsmaCancroCirúrgiaColesterolCuidados Da PeleCuidados Para Los OjosDiabetesDisfunção EréctilDiuréticosDoenças CardiovascularesEnxaquecasH I VHipertensão ArterialObesidadeOsteoporosePerturbações MentaisPerturbações NeurológicasRelaxantes MuscularesSaúde FemininaSaúde MasculinaTrato GastrointestinalTrato RespiratórioTrato Urinário 12 May 2012 06:52:11
Mylan now selling generic Lipitor in Europe Proactive Investors USA & Canada Mylan now selling generic Lipitor in Europe BusinessWeek Mylan Inc. said Friday that it is selling a low-cost generic version of the cholesterol drug Lipitor in five European countries. Mylan said it is selling its generic version in the UK, Ireland, France, Belgium and the Netherlands. Mylan Launches Generic Lipitor  in Five European Countries Mylan launches generic Lipitor in five European countries10 May 2012 16:10:10
With generics horde advancing, Pfizer gives up Lipitor push The Hindu With generics horde advancing, Pfizer gives up Lipitor push FiercePharma When Lipitor's first copycats were unleashed, Pfizer manned the battlements. With a combination of discounts, coupons and payer contracts, the drugmaker ($PFE) aimed to protect market share as long as possible. The goal: keep 40% of the market, ... Lipitor delivers impressive margins for Ranbaxy Pfizer Gives Up on Lipitor Generic Lipitor could save the NHS Â 350m a year - -10 May 2012 15:07:37
AM Vitals: Pfizer Parts With LipitorAM Vitals: Pfizer Parts With Lipitor Wall Street Journal (blog) By Christopher Weaver Goodbye, Lipitor . Pfizer Bids a Farewell (WSJ): After an $87 million marketing push since November, Pfizer is giving up on its mainstay drug Lipitor in the face of increasing competition from generic-drug makers.
10 May 2012 01:12:18
Atorvastatin Lifts Ranbaxy While Pfizer Abandons Its Lipitor Marketing Efforts Moneycontrol.com Atorvastatin Lifts Ranbaxy While Pfizer Abandons Its Lipitor Marketing Efforts Forbes Pfizer will no longer aggressively market Lipitor (atorvastatin), its former crown jewel and the most lucrative pharmaceutical product ever. At the same time, generic drug manufacturer Ranbaxy posted record revenue for the last business quarter, ... Lipitor clone delivers for Ranbaxy Pfizer stops promoting Lipitor in US Ranbaxy's Net Profit Soars -10 May 2012 00:00:31
Fewer Lipitor promotionsFewer Lipitor promotions Philadelphia Inquirer Officials from Pfizer Inc., whose blockbuster cholesterol drug Lipitor faces increased generic competition this month, told the Wall Street Journal Wednesday that the company would discontinue many of the unusual promotional programs it conducted in ... Pfizer Could Plummet Without Lipitor Replacement Lipitor marketing reaches the end of the road WSJ BLOG Health: AM Vitals: Pfizer Parts With Lipitor
09 May 2012 17:19:59
Lipitor copy powers a surge in Ranbaxy sales, profits Firstpost Lipitor copy powers a surge in Ranbaxy sales, profits FiercePharma What a difference generic Lipitor can make. Ranbaxy Laboratories' first-quarter earnings soared on its launch of the cholesterol drug copycat, to 12.47 billion rupees--$234.3 million--from 3.04 billion rupees last year. The numbers also beat analyst ... Ranbaxy Q1 profit jumps on generic Lipitor Lipitor sales help Ranbaxy clock 4-fold profit growth Ranbaxy Q1 PAT seen up, Lipitor launch helps -07 May 2012 21:51:11
Roche ends testing of cholesterol drug for lack of benefit; similar compounds ... Bloomberg Roche ends testing of cholesterol drug for lack of benefit; similar compounds ... Washington Post TRENTON, NJ â A second experimental cholesterol medicine in a once-promising class of drugs meant to replace blockbusters such as Lipitor has failed in testing, casting doubt on whether any of the drugs will ever make it to pharmacies. Summary Box: Hoped-for cholesterol drug scrapped07 May 2012 17:12:39
Beyond Lipitor: New Injections Could Help Reduce 'Bad' Cholesterol The Atlantic Beyond Lipitor : New Injections Could Help Reduce 'Bad' Cholesterol The Atlantic By Alice G. Walton The 'bad' kind of cholesterol, 'LDL,' has been effectively targeted by drugs like Lipitor known as statins. A treatment now in clinical trials could do even better. For people whose cholesterol is resistant to medication or for those ... |
|
Choose Your language:
Pesquisa no site:
Testemunhos
Olá, obrigado,
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mais vendidos|Política|Questões Mais Frequentes|Testemunhos|Contacte-nos|Sitemap |
|
|
|
|
| |